[ad_1] SAN FRANCISCO, Oct. 24, 2025 /PRNewswire/ — A securities class action, styled Bridgewood v. MoonLake Immunotherapeutics, et al., No. 1:25-cv-08500 (S.D.N.Y), has been filed after MoonLake (NASDAQ: MLTX) announced disastrous Phase 3 trial results for […]

[ad_1] SAN FRANCISCO, Oct. 21, 2025 /PRNewswire/ — A federal class-action lawsuit has been filed against aTyr Pharma, Inc. (NASDAQ: ATYR) following a devastating 83% drop in the biotech company’s stock price after its lead […]

[ad_1] SAN FRANCISCO, Oct. 14, 2025 /PRNewswire/ — Nutex Health Inc. (NASDAQ: NUTX), a publicly traded operator of micro-hospitals and healthcare facilities, is under legal scrutiny following a class-action lawsuit that accuses the company of […]

[ad_1] SAN FRANCISCO, Feb. 6, 2025 /PRNewswire/ — On Jan. 29, 2025, the price of software solutions company Manhattan Associates, Inc. (NASDAQ: MANH) tumbled $72.26 lower (-24%) after reporting its Q4 and FY 2024 financial […]

[ad_1] SAN FRANCISCO, Jan. 3, 2025 /PRNewswire/ — Shares of BioAge (NASDAQ: BIOA) have plummeted since the company’s December 6 announcement of the discontinuation of a Phase 2 trial for its weight-loss drug azelaprag due to […]